Ambulatory Blood Pressure Monitoring Should Be Used in the Primary Care Setting to Diagnose Hypertension

Davis, Trevor; Davis, Amy

doi:10.1093/ajh/hpt089

Cited by 5 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For management of hypertension to be effective, accurate BP measurements are essential. In practice, the treatment of hypertension is often based on clinic or office BP recordings [27]. These may be inaccurate due to lack of repeat measurements, diurnal variation in BP and white-coat hypertension [28].…”

Section: Measurement Of Blood Pressure (Bp) In Ckdmentioning

confidence: 99%

Management of Hypertension in Chronic Kidney Disease

Pugh

Gallacher

Dhaun

2019

Drugs

296

173

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is an increasingly prevalent condition globally and is strongly associated with incident cardiovascular disease (CVD). Hypertension is both a cause and effect of CKD and affects the vast majority of CKD patients. Control of hypertension is important in those with CKD as it leads to slowing of disease progression as well as reduced CVD risk. Existing guidelines do not offer a consensus on optimal blood pressure (BP) targets. Therefore, an understanding of the evidence used to create these guidelines is vital when considering how best to manage individual patients. Non-pharmacological interventions are useful in reducing BP in CKD but are rarely sufficient to control BP adequately. Patients with CKD and hypertension will often require a combination of antihypertensive medications to achieve target BP. Certain pharmacological therapies provide additional BP-independent renoprotective and/or cardioprotective action and this must be considered when instituting therapy. Managing hypertension in the context of haemodialysis and following kidney transplantation presents further challenges. Novel therapies may enhance treatment in the near future. Importantly, a personalised and evidence-based management plan remains key to achieving BP targets, reducing CVD risk and slowing progression of CKD.

show abstract

Section: Measurement Of Blood Pressure (Bp) In Ckdmentioning

confidence: 99%

Management of Hypertension in Chronic Kidney Disease

Pugh

Gallacher

Dhaun

2019

Drugs

296

173

View full text Add to dashboard Cite

show abstract

“…[16][17][18][19] Poor mental health and more depressive symptoms have also been associated with a diagnosis of hypertension in black subjects in the US. 20 The diagnosis and management of BP in the UK are informed by guidelines largely based on research from white populations. 4 Current adjustment between clinic and "out-of-office" thresholds for diagnosis is based on Australian data gathered in a population that was 82% white and 15% Asian.…”

Section: Introductionmentioning

confidence: 99%